Research News
Share:
BySpondylitis Association of America

When TNF inhibitor medications fail in spondyloarthritis

Biologic medications, such as TNF inhibitors (TNFi) and IL-17 inhibitors (IL-17i), are the current standard in rheumatologic treatment…

Read more
BySpondylitis Association of America

Nonradiographic Axial Spondyloarthritis: The Case for Early TNF-i Interventions in…

In a new video from MedPage Today, esteemed rheumatologist and researcher,…

Read more
BySpondylitis Association of America

A Biosimilar Version of Enbrel Gains FDA Approval

The Food and Drug Administration (FDA) approved the biologic Erelzi, (etanercept-szzs) in late August for conditions including ankylosing spondylitis…

Read more
BySpondylitis Association of America

Genetics of Ankylosing Spondylitis

Ankylosing spondylitis (AS) is considered a complex genetic disease, as more than one gene is involved. We know the importance and weight the HLA-B27 gene…

Read more
BySpondylitis Association of America

Distinguishing Clinical Features in Psoriatic Arthritis

In this new video from MD Magazine, Philip J. Mease, MD –– a respected leader in the field –– outlines…

Read more
BySpondylitis Association of America

Classification of Spondyloarthritis

In this video from MD Magazine, Dr. Philip J. Mease, MD –– a respected leader in the field –– explains the most recent classification guidelines released by…

Read more
1 17 18 19 20 21 22